Overview

Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis

Status:
Completed
Trial end date:
2017-09-29
Target enrollment:
Participant gender:
Summary
A Randomized Double-Blind, Vehicle-Controlled, Parallel Design, Multiple-Site, Phase III Clinical Study
Phase:
Phase 3
Details
Lead Sponsor:
Taro Pharmaceuticals USA